(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 15.61% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.61%.
Twist Bioscience's revenue in 2025 is $376,572,000.On average, 13 Wall Street analysts forecast TWST's revenue for 2026 to be $26,523,567,758, with the lowest TWST revenue forecast at $22,471,899,555, and the highest TWST revenue forecast at $27,800,950,021. On average, 13 Wall Street analysts forecast TWST's revenue for 2027 to be $30,528,151,981, with the lowest TWST revenue forecast at $25,827,703,222, and the highest TWST revenue forecast at $32,359,535,359.
In 2028, TWST is forecast to generate $35,918,350,472 in revenue, with the lowest revenue forecast at $33,078,636,145 and the highest revenue forecast at $37,624,380,398.